Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TRANSPLANT EIGEDOM AS
AS
Active
Org 989694073
Utleie av egen eller leid fast eiendom ellers · NACE 68209
Est. 2006
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2020
NOK 782K
+2% vs 2019
EBITDA margin
76.8%
+26% vs 2019
Equity ratio
25.6%
Financial strength
Net profit 2020
NOK 269K
+105% vs 2019
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2016
1M
+100%
2017
0M
-100%
2018
0M
0%
2019
1M
+100%
2020
Key figures
Annual report 2020
Revenue
NOK 782K
+2%
EBITDA
NOK 601K
+26%
Net profit
NOK 269K
+105%
Total assets
NOK 5,9M
+3%
Equity
NOK 1,5M
+22%
Employees
0
—
Company information
Legal name
TRANSPLANT EIGEDOM AS
Org number
989694073
Legal form
Aksjeselskap
NACE code
68209 · Utleie av egen eller leid fast eiendom ellers
Founded
6. april 2006
Share capital
NOK 73 960 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Eie, bygge og forvalte eit foretningsbygg på eigendommen gnr 63 bnr 220 i fjaler kommune.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Utleie av egen eller leid fast eiendom ellers
Companies in Fjaler
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2016
1M
2017
1M
2018
1M
2019
1M
2020
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2016
1M
2017
0M
2018
0M
2019
1M
2020
Income statement
NOK thousands
Item
2016
2017
2018
2019
2020
Revenue
639
706
748
768
782
Staff expenses
−25
−0
−0
−0
−0
EBITDA
394
572
474
478
601
Depreciation & amort.
−147
−147
−147
−147
−147
EBIT
247
425
328
331
454
Net financials
−240
−225
−187
−200
−185
Profit before tax
7
200
141
132
269
Tax
−0
−0
−0
−0
−0
Net profit
7
200
141
132
269
Balance sheet
NOK thousands
Item
2016
2017
2018
2019
2020
Total assets
5 293
5 314
5 775
5 764
5 941
Equity
778
978
1 119
1 250
1 519
Long-term debt
4 329
4 147
4 510
4 353
4 188
Short-term debt
185
189
147
161
234
Total debt
4 515
4 335
4 657
4 514
4 422
Financial ratios
5-year trend
EBITDA margin
76.8%
This company
15.8%
Market median
+386% vs market
2016
2020
Equity ratio
25.6%
This company
38.2%
Market median
-33% vs market
2016
2020
Return on equity
17.7%
This company
18.4%
Market median
+4% vs market
2016
2020
Net profit margin
34.4%
This company
8.1%
Market median
+325% vs market
2016
2020
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
2016
2020
Debt / equity
2.91×
This company
0.62×
Market median
-369% vs market
2016
2020
Annual reports & filings
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
BI
Bente Iren Nesse
Board of Directors
2020
KH
Kjetil Høgseth Felde
Chairman
2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of TRANSPLANT EIGEDOM AS also hold positions in
0
other companies.
Person
Role here
Other companies
Bente Iren Nesse
Board of Directors
0 companies
Kjetil Høgseth Felde
Chairman
0 companies